Endothelial cannabinoid CB1 receptor deficiency reduces shear stress-induced arterial inflammation and lipid uptake.
Nat Commun.
2026 Jul 7;17(1). doi: 10.1038/s41467-026-75214-2. PubMed PMID:
42414306; PubMed Central PMCID:
PMC13342577.
Correction: Circulating nitric oxide pathway metabolites in heart failure with preserved ejection fraction: a sex-stratified cross-sectional analysis.
Biol Sex Differ.
2026 Jul 6;17(1). doi: 10.1186/s13293-026-00944-3. PubMed PMID:
42410611; PubMed Central PMCID:
PMC13335291.
Myopathy in endogenous Cushing's syndrome: type II muscle fiber atrophy and its association with age and circulating IGF-1.
Endocr Connect.
2026 Jul 1;15(7). doi: 10.1530/EC-26-0355. PubMed PMID:
42447053; PubMed Central PMCID:
PMC13393306.
Spatial transcriptomics maps distinct signatures of human intermuscular adipose expansion in mice.
medRxiv.
2026 Jun 26;. doi: 10.64898/2026.04.16.26351017. PubMed PMID:
42064925; PubMed Central PMCID:
PMC13127531.
Circulating nitric oxide pathway metabolites in heart failure with preserved ejection fraction: a sex-stratified cross-sectional analysis.
Biol Sex Differ.
2026 Jun 15;17(1). doi: 10.1186/s13293-026-00940-7. PubMed PMID:
42298662; PubMed Central PMCID:
PMC13270708.
NRAC controls CD36-mediated fatty acid uptake in adipocytes and lipid clearance in vivo.
EMBO J.
2025 Sep;44(18):5037-5065. doi: 10.1038/s44318-025-00520-2. Epub 2025 Aug 1. PubMed PMID:
40750702; PubMed Central PMCID:
PMC12436663.
Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease.
Cardiovasc Diabetol.
2024 Sep 12;23(1):341. doi: 10.1186/s12933-024-02407-8. PubMed PMID:
39267039; PubMed Central PMCID:
PMC11395572.
Non-invasive optoacoustic imaging of dermal microcirculatory revascularization in diet-induced obese mice undergoing exercise intervention.
Photoacoustics.
2024 Aug;38:100628. doi: 10.1016/j.pacs.2024.100628. eCollection 2024 Aug. PubMed PMID:
39055739; PubMed Central PMCID:
PMC11269314.
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
Mol Metab.
2024 May;83:101915. doi: 10.1016/j.molmet.2024.101915. Epub 2024 Mar 14. PubMed PMID:
38492844; PubMed Central PMCID:
PMC10973979.
Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice.
Nat Metab.
2023 Dec;5(12):2075-2085. doi: 10.1038/s42255-023-00931-7. Epub 2023 Nov 9. PubMed PMID:
37946085; PubMed Central PMCID:
PMC10730394.
Regulatory T cells require IL6 receptor alpha signaling to control skeletal muscle function and regeneration.
Cell Metab.
2023 Oct 3;35(10):1736-1751.e7. doi: 10.1016/j.cmet.2023.08.010. Epub 2023 Sep 20. PubMed PMID:
37734370; PubMed Central PMCID:
PMC10563138.
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease.
Cardiovasc Diabetol.
2023 Aug 17;22(1):217. doi: 10.1186/s12933-023-01940-2. PubMed PMID:
37592302; PubMed Central PMCID:
PMC10436634.
Fasting-sensitive SUMO-switch on Prox1 controls hepatic cholesterol metabolism.
EMBO Rep.
2023 Oct 9;24(10):e55981. doi: 10.15252/embr.202255981. Epub 2023 Aug 10. PubMed PMID:
37560809; PubMed Central PMCID:
PMC10561358.
Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response.
Diabetologia.
2023 May;66(5):873-883. doi: 10.1007/s00125-023-05874-y. Epub 2023 Feb 15. PubMed PMID:
36790478; PubMed Central PMCID:
PMC10036433.
Non-invasive multispectral optoacoustic tomography resolves intrahepatic lipids in patients with hepatic steatosis.
Photoacoustics.
2023 Feb;29:100454. doi: 10.1016/j.pacs.2023.100454. eCollection 2023 Feb. PubMed PMID:
36794122; PubMed Central PMCID:
PMC9922962.
Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome.
Mol Metab.
2022 Dec;66:101616. doi: 10.1016/j.molmet.2022.101616. Epub 2022 Oct 18. PubMed PMID:
36270613; PubMed Central PMCID:
PMC9626936.
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice.
Nat Metab.
2022 Aug;4(8):1071-1083. doi: 10.1038/s42255-022-00617-6. Epub 2022 Aug 22. PubMed PMID:
35995995; PubMed Central PMCID:
PMC9398908.
Research in metabolic ageing - a tale of mice versus humans?.
Nat Rev Endocrinol.
2022 Jan;18(1):7-8. doi: 10.1038/s41574-021-00597-9. PubMed PMID:
34824384.
Functional multispectral optoacoustic tomography imaging of hepatic steatosis development in mice.
EMBO Mol Med.
2021 Sep 7;13(9):e13490. doi: 10.15252/emmm.202013490. Epub 2021 Aug 19. PubMed PMID:
34411447; PubMed Central PMCID:
PMC8422073.
The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.
Cell Metab.
2021 Apr 6;33(4):833-844.e5. doi: 10.1016/j.cmet.2021.01.015. Epub 2021 Feb 10. PubMed PMID:
33571454; PubMed Central PMCID:
PMC8035082.
Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice.
Diabetes Obes Metab.
2021 Jan;23(1):195-207. doi: 10.1111/dom.14215. Epub 2020 Nov 5. PubMed PMID:
33001570.
Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission.
Nat Metab.
2020 Apr;2(4):380. doi: 10.1038/s42255-020-0201-1. PubMed PMID:
33820985.
Targeted pharmacological therapy restores β-cell function for diabetes remission.
Nat Metab.
2020 Feb;2(2):192-209. doi: 10.1038/s42255-020-0171-3. Epub 2020 Feb 20. PubMed PMID:
32694693.
Glucagon Regulation of Energy Expenditure.
Int J Mol Sci.
2019 Oct 30;20(21). doi: 10.3390/ijms20215407. Review. PubMed PMID:
31671603; PubMed Central PMCID:
PMC6862306.
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.
Mol Syst Biol.
2019 Mar 1;15(3):e8793. doi: 10.15252/msb.20188793. PubMed PMID:
30824564; PubMed Central PMCID:
PMC6396370.
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases.
Nat Rev Endocrinol.
2019 Feb;15(2):90-104. doi: 10.1038/s41574-018-0118-x. Review. PubMed PMID:
30446744.
Gene-by-Sex Interactions in Mitochondrial Functions and Cardio-Metabolic Traits.
Cell Metab.
2019 Apr 2;29(4):932-949.e4. doi: 10.1016/j.cmet.2018.12.013. Epub 2019 Jan 10. PubMed PMID:
30639359; PubMed Central PMCID:
PMC6447452.
Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans.
Am J Physiol Endocrinol Metab.
2019 May 1;316(5):E866-E879. doi: 10.1152/ajpendo.00243.2018. Epub 2019 Jan 8. PubMed PMID:
30620635; PubMed Central PMCID:
PMC6580171.
Corrigendum to "Deficiency of leptin receptor in myeloid cells disrupts hypothalamic metabolic circuits and causes body weight increase" [Molecular Metabolism 7 (2018) 155-160].
Mol Metab.
2019 Feb;20:205. doi: 10.1016/j.molmet.2018.12.006. Epub 2018 Dec 24. PubMed PMID:
30594493; PubMed Central PMCID:
PMC6358568.
Preadipocytes of obese humans display gender-specific bioenergetic responses to glucose and insulin.
Mol Metab.
2019 Feb;20:28-37. doi: 10.1016/j.molmet.2018.11.006. Epub 2018 Nov 26. PubMed PMID:
30528280; PubMed Central PMCID:
PMC6358537.
Publisher Correction: Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes.
Nat Commun.
2018 Nov 20;9(1):4975. doi: 10.1038/s41467-018-07479-1. PubMed PMID:
30459311; PubMed Central PMCID:
PMC6246605.
Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes.
Nat Commun.
2018 Oct 23;9(1):4304. doi: 10.1038/s41467-018-06769-y. PubMed PMID:
30353008; PubMed Central PMCID:
PMC6199300.
Circulating HDL levels control hypothalamic astrogliosis via apoA-I.
J Lipid Res.
2018 Sep;59(9):1649-1659. doi: 10.1194/jlr.M085456. Epub 2018 Jul 10. PubMed PMID:
29991652; PubMed Central PMCID:
PMC6121940.
Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs.
Mol Metab.
2018 Oct;16:180-190. doi: 10.1016/j.molmet.2018.06.015. Epub 2018 Jun 28. PubMed PMID:
30017782; PubMed Central PMCID:
PMC6157610.
Animal models of obesity and diabetes mellitus.
Nat Rev Endocrinol.
2018 Mar;14(3):140-162. doi: 10.1038/nrendo.2017.161. Epub 2018 Jan 19. Review. PubMed PMID:
29348476.
Deficiency of leptin receptor in myeloid cells disrupts hypothalamic metabolic circuits and causes body weight increase.
Mol Metab.
2018 Jan;7:155-160. doi: 10.1016/j.molmet.2017.11.003. Epub 2017 Nov 9. PubMed PMID:
29174000; PubMed Central PMCID:
PMC5784319.
Lipoprotein Lipase Maintains Microglial Innate Immunity in Obesity.
Cell Rep.
2017 Sep 26;20(13):3034-3042. doi: 10.1016/j.celrep.2017.09.008. PubMed PMID:
28954222.
Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity.
Cell Metab.
2017 Oct 3;26(4):620-632.e6. doi: 10.1016/j.cmet.2017.08.023. Epub 2017 Sep 21. PubMed PMID:
28943448.
A history of obesity leaves an inflammatory fingerprint in liver and adipose tissue.
Int J Obes (Lond).
2018 Mar;42(3):507-517. doi: 10.1038/ijo.2017.224. Epub 2017 Sep 13. PubMed PMID:
28901330; PubMed Central PMCID:
PMC5880583.
Activated macrophages control human adipocyte mitochondrial bioenergetics via secreted factors.
Mol Metab.
2017 Oct;6(10):1226-1239. doi: 10.1016/j.molmet.2017.07.008. Epub 2017 Jul 19. PubMed PMID:
29031722; PubMed Central PMCID:
PMC5641636.
Sex in basic research: concepts in the cardiovascular field.
Cardiovasc Res.
2017 Jun 1;113(7):711-724. doi: 10.1093/cvr/cvx066. Review. PubMed PMID:
28472454.
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.
Mol Metab.
2017 May;6(5):440-446. doi: 10.1016/j.molmet.2017.02.002. eCollection 2017 May. PubMed PMID:
28462078; PubMed Central PMCID:
PMC5404097.
Teneurin-2 (TENM2) deficiency induces UCP1 expression in differentiating human fat cells.
Mol Cell Endocrinol.
2017 Mar 5;443:106-113. doi: 10.1016/j.mce.2017.01.015. Epub 2017 Jan 11. PubMed PMID:
28088466.
Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance.
EBioMedicine.
2017 Feb;16:204-211. doi: 10.1016/j.ebiom.2017.01.006. Epub 2017 Jan 7. PubMed PMID:
28111237; PubMed Central PMCID:
PMC5474437.
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.
Cell.
2016 Oct 20;167(3):843-857.e14. doi: 10.1016/j.cell.2016.09.014. Epub 2016 Oct 6. PubMed PMID:
27720451.
High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties.
Mol Metab.
2016 May;5(5):321-327. doi: 10.1016/j.molmet.2016.03.001. eCollection 2016 May. Review. PubMed PMID:
27110484; PubMed Central PMCID:
PMC4837296.
Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice.
EMBO Mol Med.
2015 Mar;7(3):288-98. doi: 10.15252/emmm.201404508. PubMed PMID:
25652173; PubMed Central PMCID:
PMC4364946.
The good, the bad, and the unknown: Fructose and FGF21.
Mol Metab.
2015 Jan;4(1):1-2. doi: 10.1016/j.molmet.2014.11.002. eCollection 2015 Jan. PubMed PMID:
25685684; PubMed Central PMCID:
PMC4314528.
The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms.
Nat Commun.
2013;4:1968. doi: 10.1038/ncomms2968. PubMed PMID:
23744028; PubMed Central PMCID:
PMC3709495.
GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet.
Diabetes.
2014 Apr;63(4):1422-7. doi: 10.2337/db13-1609. Epub 2013 Dec 30. PubMed PMID:
24379349.
What would you like to do?